New Enterprise Associates 17, L.P.

Overview

• HeadquartersDE¹

See how the biggest companies compare on our leaderboards

Corporate structure

New Enterprise Associates 17, L.P. sits at the top of its group. 7 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (6 companies). Each entity in the chart links to its source.

Stakes it holds

New Enterprise Associates 17, L.P. has told the SEC it owns more than 5% of 6 companies, latest first (Schedules 13D and 13G).

• Monte Rosa TherapeuticsSCHEDULE 13D/A May 13, 2024 to Jul 6, 2026²
• Inventiva S.A.SCHEDULE 13D/A May 3, 2024 to Apr 1, 2026³
• Korro Bio, Inc.SCHEDULE 13D/A Nov 17, 2023 to Mar 12, 2026⁴
• SpyGlass Pharma, Inc.SCHEDULE 13D Feb 13, 2026⁵
• MBX Biosciences, Inc.SCHEDULE 13D/A Sep 23, 2024 to Nov 10, 2025⁶
• Bright HealthSCHEDULE 13D/A Dec 26, 2024 to Oct 6, 2025⁷